108 related articles for article (PubMed ID: 21083601)
1. Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours.
Polo SE; Theocharis SE; Grandin L; Gambotti L; Antoni G; Savignoni A; Asselain B; Patsouris E; Almouzni G
Histopathology; 2010 Nov; 57(5):716-24. PubMed ID: 21083601
[TBL] [Abstract][Full Text] [Related]
2. The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours.
Staibano S; Mascolo M; Rocco A; Lo Muzio L; Ilardi G; Siano M; Pannone G; Vecchione ML; Nugnes L; Califano L; Zamparese R; Bufo P; De Rosa G
Oncol Rep; 2011 Jan; 25(1):13-22. PubMed ID: 21109952
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
Staibano S; Mascolo M; Mancini FP; Kisslinger A; Salvatore G; Di Benedetto M; Chieffi P; Altieri V; Prezioso D; Ilardi G; De Rosa G; Tramontano D
Histopathology; 2009 Apr; 54(5):580-9. PubMed ID: 19309489
[TBL] [Abstract][Full Text] [Related]
4. Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue?
Staibano S; Mignogna C; Lo Muzio L; Mascolo M; Salvatore G; Di Benedetto M; Califano L; Rubini C; De Rosa G
Histopathology; 2007 Jun; 50(7):911-9. PubMed ID: 17543081
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
7. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
8. Histone metabolic pathways and chromatin assembly factors as proliferation markers.
Polo SE; Almouzni G
Cancer Lett; 2005 Mar; 220(1):1-9. PubMed ID: 15737682
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer.
Gasinska A; Kolodziejski L; Niemiec J; Dyczek S
Lung Cancer; 2005 Aug; 49(2):171-9. PubMed ID: 16022910
[TBL] [Abstract][Full Text] [Related]
12. [Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine].
Ahlin C; Fernö M; Amini RM; Tolockiene E; Blomqvist C; Bergh J; Fjällskog ML
Lakartidningen; 2010 Mar 10-16; 107(10):672-5. PubMed ID: 20402250
[No Abstract] [Full Text] [Related]
13. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients.
Wiesner FG; Magener A; Fasching PA; Wesse J; Bani MR; Rauh C; Jud S; Schrauder M; Loehberg CR; Beckmann MW; Hartmann A; Lux MP
Breast; 2009 Apr; 18(2):135-41. PubMed ID: 19342238
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
15. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
[TBL] [Abstract][Full Text] [Related]
16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
18. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ
Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
